Henry B. Lowman

Person

EI Granada, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for conjugating activatable antibodies
- Patent number 11,992,528
- Issue date May 28, 2024
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 11,890,354
- Issue date Feb 6, 2024
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Grant
Method of treating or delaying progression of an epidermal growth f...
- Patent number 11,180,562
- Issue date Nov 23, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multispecific antibodies, multispecific activatable antibodies and...
- Patent number 11,161,906
- Issue date Nov 2, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable antibodies having non-binding steric moieties and metho...
- Patent number 10,894,821
- Issue date Jan 19, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 10,709,799
- Issue date Jul 14, 2020
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding activatable antibodies that bind epidermal g...
- Patent number 10,533,053
- Issue date Jan 14, 2020
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-...
- Patent number 10,301,380
- Issue date May 28, 2019
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 9,889,211
- Issue date Feb 13, 2018
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies having non-binding steric moieties and metho...
- Patent number 9,856,314
- Issue date Jan 2, 2018
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-...
- Patent number 9,688,748
- Issue date Jun 27, 2017
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-factor D antibodies and uses thereof
- Patent number 9,676,868
- Issue date Jun 13, 2017
- Genentech, Inc.
- Arthur Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 9,545,442
- Issue date Jan 17, 2017
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 9,540,440
- Issue date Jan 10, 2017
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for conjugating activatable antibodies
- Patent number 9,517,276
- Issue date Dec 13, 2016
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Assays for detecting antibodies specific to therapeutic anti-IgE an...
- Patent number 9,315,583
- Issue date Apr 19, 2016
- Genentech, Inc.
- Saloumeh Fischer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-...
- Patent number 9,127,053
- Issue date Sep 8, 2015
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 9,120,853
- Issue date Sep 1, 2015
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-HER2 antibody variants
- Patent number 8,840,896
- Issue date Sep 23, 2014
- Genentech, Inc.
- Henry B. Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of detecting factor D with anti-factor D antibodies
- Patent number 8,753,826
- Issue date Jun 17, 2014
- Genentech, Inc.
- Ling-Ling An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody variants
- Patent number 8,703,133
- Issue date Apr 22, 2014
- Genentech, Inc.
- Yvonne M. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polynucleotides encoding humanized anti-factor D antibodies
- Patent number 8,614,306
- Issue date Dec 24, 2013
- Genentech, Inc.
- Arthur Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin variants and uses thereof
- Patent number 8,562,992
- Issue date Oct 22, 2013
- Genentech, Inc.
- Camellia W. Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-factor D antibodies and uses thereof
- Patent number 8,372,403
- Issue date Feb 12, 2013
- Genentech, Inc.
- Ling-Ling An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cysteine engineered antibodies and conjugates
- Patent number 8,309,300
- Issue date Nov 13, 2012
- Genentech, Inc.
- Jagath Reddy Junutula
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-factor D antibodies and uses thereof
- Patent number 8,273,352
- Issue date Sep 25, 2012
- Genentech, Inc.
- Arthur Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding anti-factor D antibodies
- Patent number 8,193,329
- Issue date Jun 5, 2012
- Genentech, Inc.
- Ling-Ling An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating with anti-factor D antibodies
- Patent number 8,187,604
- Issue date May 29, 2012
- Genentech, Inc.
- Ling-Ling An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating cartilage disorders
- Patent number 8,110,548
- Issue date Feb 7, 2012
- Genentech, Inc.
- Yvonne Man-Yee Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IGF-I protein variants for treating IGFBP-1-related disorders
- Patent number 8,097,587
- Issue date Jan 17, 2012
- Genentech, Inc.
- Yves Dubaquie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD OF TREATING OR DELAYING PROGRESSION OF AN EPIDERMAL GROWTH F...
- Publication number 20220289853
- Publication date Sep 15, 2022
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES
- Publication number 20220088192
- Publication date Mar 24, 2022
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOGLOBULIN VARIANTS AND USES THEREOF
- Publication number 20220002430
- Publication date Jan 6, 2022
- Genentech, Inc.
- Camellia W. ADAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE ANTIBODIES HAVING NON-BINDING STERIC MOIETIES AND METHO...
- Publication number 20210309727
- Publication date Oct 7, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND...
- Publication number 20210238291
- Publication date Aug 5, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...
- Publication number 20210023243
- Publication date Jan 28, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Application
IMMUNOGLOBULIN VARIANTS AND USES THEREOF
- Publication number 20210002359
- Publication date Jan 7, 2021
- Genentech, Inc.
- Henry B. LOWMAN
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...
- Publication number 20200270350
- Publication date Aug 27, 2020
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-JAGGED 1/JAGGED 2 CROSS-REACTIVE ANTIBODIES, ACTIVATABLE ANTI-...
- Publication number 20190367589
- Publication date Dec 5, 2019
- CytomX Therapeutics, Inc.
- James William WEST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY VARIANTS
- Publication number 20190202902
- Publication date Jul 4, 2019
- Genentech, Inc.
- Yvonne M. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
- Publication number 20190185579
- Publication date Jun 20, 2019
- Genentech, Inc.
- Arthur Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOGLOBULIN VARIANTS WITH ALTERED BINDING TO PROTEIN A
- Publication number 20190085094
- Publication date Mar 21, 2019
- Genentech, Inc.
- Yik Andy Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOGLOBULIN VARIANTS AND USES THEREOF
- Publication number 20190071511
- Publication date Mar 7, 2019
- Genentech, Inc.
- Camellia W. ADAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...
- Publication number 20180333507
- Publication date Nov 22, 2018
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE ANTIBODIES HAVING NON-BINDING STERIC MOIETIES AND METHO...
- Publication number 20180298085
- Publication date Oct 18, 2018
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Application
ANTI-HER2 ANTIBODY VARIANTS
- Publication number 20180201692
- Publication date Jul 19, 2018
- Genentech, Inc.
- Henry B. LOWMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
- Publication number 20180100024
- Publication date Apr 12, 2018
- Genentech, Inc.
- Arthur Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES
- Publication number 20180000962
- Publication date Jan 4, 2018
- Genentech, Inc.
- Charles W. Eigenbrot
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
ANTI-VEGF ANTIBODIES
- Publication number 20170369564
- Publication date Dec 28, 2017
- Genentech, Inc.
- Manuel Baca
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-JAGGED 1/JAGGED 2 CROSS-REACTIVE ANTIBODIES, ACTIVATABLE ANTI-...
- Publication number 20170298125
- Publication date Oct 19, 2017
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...
- Publication number 20170196996
- Publication date Jul 13, 2017
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Application
ANTI-HER2 ANTIBODY VARIANTS
- Publication number 20170166656
- Publication date Jun 15, 2017
- Genentech, Inc.
- Henry B. LOWMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
- Publication number 20170166630
- Publication date Jun 15, 2017
- Genentech, Inc.
- Ling-Ling An
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOGLOBULIN VARIANTS AND USES THEREOF
- Publication number 20170158773
- Publication date Jun 8, 2017
- Genentech, Inc.
- Camellia W. ADAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY VARIANTS
- Publication number 20170096480
- Publication date Apr 6, 2017
- Genentech, Inc.
- Yvonne M. CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...
- Publication number 20170096489
- Publication date Apr 6, 2017
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES
- Publication number 20170072067
- Publication date Mar 16, 2017
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOGLOBULIN VARIANTS WITH ALTERED BINDING TO PROTEIN A
- Publication number 20160369007
- Publication date Dec 22, 2016
- Genentech, Inc.
- Yik Andy Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-VEGF ANTIBODIES
- Publication number 20160257738
- Publication date Sep 8, 2016
- Genentech, Inc.
- Manuel Baca
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-Jagged 1/Jagged 2 Cross-Reactive Antibodies, Activatable Anti-...
- Publication number 20160200826
- Publication date Jul 14, 2016
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Henry B. Lowman

Person

Patents Grantslast 30 patents

Compositions and methods for conjugating activatable antibodies

Activatable antibodies that bind epidermal growth factor receptor a...

Method of treating or delaying progression of an epidermal growth f...

Multispecific antibodies, multispecific activatable antibodies and...

Activatable antibodies having non-binding steric moieties and metho...

Activatable antibodies that bind epidermal growth factor receptor a...

Nucleic acids encoding activatable antibodies that bind epidermal g...

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-...

Activatable antibodies that bind epidermal growth factor receptor a...

Activatable antibodies having non-binding steric moieties and metho...

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-...

Humanized anti-factor D antibodies and uses thereof

Activatable antibodies that bind epidermal growth factor receptor a...

Activatable antibodies that bind epidermal growth factor receptor a...

Compositions and methods for conjugating activatable antibodies

Assays for detecting antibodies specific to therapeutic anti-IgE an...

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-...

Activatable antibodies that bind epidermal growth factor receptor a...

Anti-HER2 antibody variants

Methods of detecting factor D with anti-factor D antibodies

Antibody variants

Polynucleotides encoding humanized anti-factor D antibodies

Immunoglobulin variants and uses thereof

Humanized anti-factor D antibodies and uses thereof

Cysteine engineered antibodies and conjugates

Humanized anti-factor D antibodies and uses thereof

Nucleic acids encoding anti-factor D antibodies

Methods of treating with anti-factor D antibodies

Method for treating cartilage disorders

IGF-I protein variants for treating IGFBP-1-related disorders

Patents Applicationslast 30 patents

METHOD OF TREATING OR DELAYING PROGRESSION OF AN EPIDERMAL GROWTH F...

COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES

IMMUNOGLOBULIN VARIANTS AND USES THEREOF

ACTIVATABLE ANTIBODIES HAVING NON-BINDING STERIC MOIETIES AND METHO...

MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND...

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...

IMMUNOGLOBULIN VARIANTS AND USES THEREOF

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...

ANTI-JAGGED 1/JAGGED 2 CROSS-REACTIVE ANTIBODIES, ACTIVATABLE ANTI-...

ANTIBODY VARIANTS

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

IMMUNOGLOBULIN VARIANTS WITH ALTERED BINDING TO PROTEIN A

IMMUNOGLOBULIN VARIANTS AND USES THEREOF

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...

ACTIVATABLE ANTIBODIES HAVING NON-BINDING STERIC MOIETIES AND METHO...

ANTI-HER2 ANTIBODY VARIANTS

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES

ANTI-VEGF ANTIBODIES

ANTI-JAGGED 1/JAGGED 2 CROSS-REACTIVE ANTIBODIES, ACTIVATABLE ANTI-...

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...

ANTI-HER2 ANTIBODY VARIANTS

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

IMMUNOGLOBULIN VARIANTS AND USES THEREOF

ANTIBODY VARIANTS

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...

COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES

IMMUNOGLOBULIN VARIANTS WITH ALTERED BINDING TO PROTEIN A

ANTI-VEGF ANTIBODIES

Anti-Jagged 1/Jagged 2 Cross-Reactive Antibodies, Activatable Anti-...